1. "2012"
Formats
  1. Journal Article (2365)
  2. Meeting Abstract (1182)
  3. Book Section (137)
  4. Conference Paper (23)
  5. Book Whole (10)
  6. Correspondence (1)
  7. Editorial (1)
Groups
  1. Department of Medicine (1284)
  2. Surgery (899)
  3. GSK Faculty (811)
  4. Solid Tumor Oncology Division (708)
  5. Survivorship Research (632)
  6. Sloan Kettering Institute Faculty (579)

More Groups

People
  1. Clifford Hudis (64)
  2. Nancy Lee (64)
  3. Sergio Giralt (59)
  4. Robert Motzer (57)
  5. Richard Barakat (54)
  6. Howard Scher (53)

More People

Years
  1. 2012 (3719)
Publications
  1. Journal of Clinical Oncology (315)
  2. Blood (152)
  3. International Journal of Radiation Oncology, Biology, Physics (125)
  4. Cancer Research (110)
  5. Modern Pathology (80)
  6. Gynecologic Oncology (76)

More Publications

Publishers
  1. Elsevier Inc. (519)
  2. American Society of Clinical Oncology (337)
  3. Springer (239)
  4. Nature Publishing Group (202)
  5. Wiley Blackwell (193)
  6. American Association for Cancer Research (192)

More Publishers

Results (3719)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • (124)I-cG250 PET scan for early detection of response to sunitinib in patients (Pts) with metastatic clear cell renal cell carcinoma (MccRCC)
    Meeting Abstract

    Larson, S. M.; Motzer, R. J.; Pandit-Taskar, N.; Bartz, R.; Feldman, D. R.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Chronic kidney disease and the risk of incident renal and urothelial cancer in a population-based cohort of 1.2 million adults
    Meeting Abstract

    Lowrance, W. T.; Udaltsova, N.; Ordonez, J.; Russo, P.; Go, A. S.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase I/II safety and pharmacokinetic (PK) study of ARN-509 in patients with metastatic castration-resistant prostate cancer (mCRPC): Phase I results of a Prostate Cancer Clinical Trials Consortium study
    Meeting Abstract

    Rathkopf, D. E.; Danila, D. C.; Morris, M. J.; Slovin, S. F.; Steinbrecher, J. E.; Arauz, G.; Rix, P. J.; Maneval, E. C.; Chen, I.; Fox, J. J.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A retrospective analysis of data from two trials of sunitinib in patients with advanced renal cell carcinoma (RCC): Pitfalls of efficacy subgroup analyses based on dose-reduction status
    Meeting Abstract

    Khosravan, R.; Huang, X.; Wiltshire, R.; Lechuga, M.; Motzer, R. J.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase III AXIS trial for second-line metastatic renal cell carcinoma (mRCC): Effect of prior first-line treatment duration and axitinib dose titration on axitinib efficacy
    Meeting Abstract

    Rini, B. I.; Escudier, B. J.; Michaelson, M. D.; Negrier, S.; Gore, M. E.; Oudard, S.; Clark, J.; Tarazi, J. C.; Rosbrook, B.; Kim, S.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • External beam radiotherapy for small cell carcinoma of the urinary bladder: The Memorial Sloan-Kettering experience
    Meeting Abstract

    Kollmeier, M.; Kan, C. C.; Bochner, B.; Dalbagni, G.; Bajorin, D. F.; Zelefsky, M. J.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Pilot study of veliparib (ABT-888) with temozolomide (TMZ) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Hussain, M.; Carducci, M. A.; Slovin, S. F.; Cetnar, J. P.; Qian, J.; McKeegan, E. M.; Litvinovich, E.; Chyla, B.; Hetman, R.; Desai, B.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Comparison of PSA, FDG-PET, and Prostate Cancer Working Group 2 (PCWG2) criteria to interpret apparent progression on first post-treatment bone scan
    Meeting Abstract

    Autio, K. A.; Fox, J. J.; Haupt, E. C.; Schoder, H.; Scher, H. I.; Larson, S. M.; Morris, M. J.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Pain control and delay in time to skeletal-related events (SREs) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone acetate (AA): Long-term follow-up
    Meeting Abstract

    Basch, E. M.; De Bono, J. S.; Scher, H. I.; Molina, A.; Sternberg, C. N.; Fizazi, K.; North, S. A.; Chi, K. N.; Jones, R. J.; Goodman, O. B.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Evaluating the effect of tobacco on prostate cancer outcomes with VEGF-targeted therapy
    Meeting Abstract

    Harzstark, A. L.; Halabi, S.; Kelly, W. K.; Morris, M. J.; Febbo, P. G.; Small, E. J.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save